AI assistant
Sending…
MANNKIND CORP — Director's Dealing 2023
May 27, 2023
31835_dirs_2023-05-26_df4d3945-164f-49cf-8ff7-70c1b290c397.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2023-05-24
Reporting Person: BLANK BURKHARD (EVP Chief Medical Officer)
More from MANNKIND CORP
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26